Retreatment with sofosbuvir and simeprevir of patients with hepatitis C virus genotype 1 or 4 who previously failed a daclatasvir-containing regimen.
Christophe HEZODE,
Stephane CHEVALIEZ,
G Scoazec,
Alexandre SOULIER,
A Varaut,
Magali BOUVIER-ALIAS,
Isaac RUIZ,
F Roudot-Thoraval,
A Mallat,
Cyrille FERAY,
Jean-Michel PAWLOTSKY,
Hepatology 01/06/2016;63(6) : 1809-1816 10.1002/hep.28491 10/03/2016
Acute kidney injury following hepatectomy for hepatocellular carcinoma: incidence, risk factors and prognostic value.
C Lim,
E Audureau,
C Salloum,
E Levesque,
E Lahat,
JC Merle,
P Compagnon,
G Dhonneur,
Cyrille FERAY,
D Azoulay,
HPB (Oxford). 01/06/2016;18(6) : 540-548 10.1016/j.hpb.2016.04.004. 07/05/2016
Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.
AT Song,
R Sobesky,
C Vinaixa,
J Dumortier,
S Radenne,
F Durand,
Y Calmus,
G Rousseau,
M Latournerie,
Cyrille FERAY,
V Delvart,
B Roche,
S Haim-Boukobza,
AM Roque-Afonso,
D Castaing,
E Abdala,
LA D'Albuquerque,
JC Duclos-Vallee,
M Berenguer,
D Samuel,
World J Gastroenterol. 14/05/2016;22(18) : 4547-4558 10.3748/wjg.v22.i18.4547.
Specialization of Hepatitis C Virus Envelope Glycoproteins for B Lymphocytes in Chronically Infected Patients.
F Douam,
LM Bobay,
G Maurin,
J Fresquet,
N Calland,
C Maisse,
T Durand,
FL Cosset,
Cyrille FERAY,
D Lavillette,
J Virol. 04/11/2015;90(2) : 992-1008 10.1128/JVI.02516-15.
Risk factors for hepatocellular carcinoma in Caucasian patients with non-viral cirrhosis: the importance of prior obesity.
I Archambeaud,
H Auble,
P Nahon,
L Planche,
G Fallot,
R Faroux,
J Gournay,
D Samuel,
S Kury,
Cyrille FERAY,
Liver Int. 01/07/2015;35(7) : 1872-1876 10.1111/liv.12767 21/01/2015